Article info
Law, ethics and medicine
A theoretical flaw in the advance market commitment idea
- Correspondence to Jorn Sonderholm; jorn13{at}gmail.com
Citation
A theoretical flaw in the advance market commitment idea
Publication history
- Received September 4, 2009
- Revised October 28, 2009
- Accepted November 23, 2009
- First published June 7, 2010.
Online issue publication
June 07, 2010
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Other content recommended for you
- How should GAVI build on its success?
- Innovative financing to fund surgical systems and expand surgical care in low-income and middle-income countries
- It is not too late to achieve global covid-19 vaccine equity
- Rethinking global access to vaccines
- Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries
- Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis
- A pneumococcal vaccine is launched in Africa to cut child deaths
- Political economy of covid-19: extractive, regressive, competitive
- Market-driven, value-based, advance commitment (MVAC): accelerating the development of a pathbreaking universal drug regimen to end TB
- Towards a new model of global health justice: the case of COVID-19 vaccines